Novartis AG Other Non-Current Liabilities 2010-2024 | NVS

Novartis AG other non-current liabilities for the quarter ending September 30, 2024 were $4.389B, a 7.55% increase year-over-year.

  • Novartis AG other non-current liabilities for 2023 were $4.523B, a 7.81% decline from 2022.
  • Novartis AG other non-current liabilities for 2022 were $4.906B, a 20.51% decline from 2021.
  • Novartis AG other non-current liabilities for 2021 were $6.172B, a 10.99% decline from 2020.

Novartis AG Other Non-Current Liabilities 2010-2024 | NVS

  • Novartis AG other non-current liabilities for 2023 were $4.523B, a 7.81% decline from 2022.
  • Novartis AG other non-current liabilities for 2022 were $4.906B, a 20.51% decline from 2021.
  • Novartis AG other non-current liabilities for 2021 were $6.172B, a 10.99% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B